The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders

British Journal of Pharmacology

Volumn 164, Issue 4, 2011, Pages 1301-1321

  Winstanley, Catharine A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

CPT; delay discounting; dopamine; five choice serial reaction time task; glutamate; go no go; impulsivity; noradrenaline; serotonin; stop signal task

Indexed keywords

1,4 BENZODIOXAN 6 CARBOXYLIC ACID PIPERIDIDE; 6 QUINOXALINECARBOXYLIC ACID PIPERIDIDE; ADX 47273; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMFEBUTAMONE; AMPHETAMINE; ATIPAMEZOLE; ATOMOXETINE; BUSPIRONE; CITALOPRAM; CLONIDINE; COCAINE; DESIPRAMINE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; GLUTAMATE RECEPTOR AGONIST; GUANFACINE; LEVODOPA; METHYLPHENIDATE; NORADRENALIN; PAROXETINE; PHENYLEPHRINE; PRAMIPEXOLE; PRAZOSIN; PROPRANOLOL; SEROTONIN; SEROTONIN AGONIST; UNCLASSIFIED DRUG; UNINDEXED DRUG; VOLINANSERIN; YOHIMBINE;

CONTINUOUS PERFORMANCE TASK; DECISION MAKING; DELAY DISCOUNTING TASK; DISEASE MODEL; DRUG RESEARCH; DRUG TARGETING; EXPERIMENTAL TEST; GO NO-GO TASK; HUMAN; HYPERACTIVITY; IMPULSE CONTROL DISORDER; IMPULSIVENESS; METHODOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; ORBITAL CORTEX; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; REVIEW; REWARD; SPECIES DIFFERENCE; STOP SIGNAL TASK; SUBTHALAMIC NUCLEUS; TASK PERFORMANCE; VALIDITY;

ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; DOPAMINE; HUMANS; IMPULSE CONTROL DISORDERS; IMPULSIVE BEHAVIOR; RATS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 80053328809     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01323.x     Document Type: Review

References (242)

1. Acheson A, de Wit H, (2008). Bupropion improves attention but does not affect impulsive behavior in healthy young adults. Exp Clin Psychopharmacol 16: 113-123. (Pubitemid 351680704)
2. Adida M, Clark L, Pomietto P, Kaladjian A, Besnier N, Azorin JM, et al,. (2008). Lack of insight may predict impaired decision making in manic patients. Bipolar Disord 10: 829-837.
3. Aggarwal A, Lillystone D, (2000). A follow-up pilot study of objective measures in children with attention deficit hyperactivity disorder. J Paediatr Child Health 36: 134-138. (Pubitemid 30190597)
4. Ainslie G, (1975). Specious reward: a behavioral theory of impulsiveness and impulse control. Psychol Bull 82: 463-498.
5. Almeida S, Glahn DC, Argyropoulos SV, Frangou S, (2010). Acute citalopram administration may disrupt contextual information processing in healthy males. Eur Psychiatry 25: 87-91.
6. Amitai Y, Frischer H, (2006). Excess fatality from desipramine in children and adolescents. J Am Acad Child Adolesc Psychiatry 45: 54-60. (Pubitemid 41818141)
7. Arnsten AF, (2009). Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction. CNS Drugs 23 (Suppl. 1): 33-41.
8. Arnsten AF, Scahill L, Findling RL, (2007). alpha2-Adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data. J Child Adolesc Psychopharmacol 17: 393-406.
9. Aron AR, Dowson JH, Sahakian BJ, Robbins TW, (2003). Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 54: 1465-1468. (Pubitemid 37522172)
10. Ballon JS, Feifel D, (2006). A systematic review of modafinil: potential clinical uses and mechanisms of action. J Clin Psychiatry 67: 554-566. (Pubitemid 43764232)
11. Bari A, Eagle DM, Mar AC, Robinson ES, Robbins TW, (2009). Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats. Psychopharmacology (Berl) 205: 273-283.
12. Barkley RA, DuPaul GJ, McMurray MB, (1991). Attention deficit disorder with and without hyperactivity: clinical response to three dose levels of methylphenidate. Pediatrics 87: 519-531.
13. Barnes NM, Sharp T, (1999). A review of central 5-HT receptors and their function. Neuropharmacology 38: 1083-1152. (Pubitemid 29292403)
14. Barry RJ, Clarke AR, Hajos M, McCarthy R, Selikowitz M, Bruggemann JM, (2009). Acute atomoxetine effects on the EEG of children with attention-deficit/hyperactivity disorder. Neuropharmacology 57: 702-707.
15. Baunez C, Robbins TW, (1997). Bilateral lesions of the subthalamic nucleus induce multiple deficits in an attentional task in rats. Eur J Neurosci 9: 2086-2099. (Pubitemid 27485241)
16. Bechara A, Damasio AR, Damasio H, Anderson SW, (1994). Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 50: 7-15.
17. Bechara A, Dolan S, Denburg N, Hindes A, Anderson SW, Nathan PE, (2001). Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia 39: 376-389. (Pubitemid 32065803)
18. Bechara A, Dolan S, Hindes A, (2002). Decision-making and addiction (part II): myopia for the future or hypersensitivity to reward? Neuropsychologia 40: 1690-1705. (Pubitemid 34462877)
19. Belin D, Mar AC, Dalley JW, Robbins TW, Everitt BJ, (2008). High impulsivity predicts the switch to compulsive cocaine-taking. Science 320: 1352-1355. (Pubitemid 351929473)
20. van den Bergh FS, Bloemarts E, Groenink L, Olivier B, Oosting RS, (2006). Delay aversion: effects of 7-OH-DPAT, 5-HT1A/1B-receptor stimulation and d-cycloserine. Pharmacol Biochem Behav 85: 736-743. (Pubitemid 46157138)
21. Bickel WK, Marsch LA, (2001). Toward a behavioral economic understanding of drug dependence: delay discounting processes. Addiction 96: 73-86. (Pubitemid 32099341)
22. Biederman J, Spencer T, (1999). Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol Psychiatry 46: 1234-1242. (Pubitemid 30114440)
23. Biederman J, Swanson JM, Wigal SB, Kratochvil CJ, Boellner SW, Earl CQ, et al,. (2005). Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study. Pediatrics 116: e777-e784. (Pubitemid 46056456)
24. Biederman J, Arnsten AF, Faraone SV, Doyle AE, Spencer TJ, Wilens TE, et al,. (2006). New developments in the treatment of ADHD. J Clin Psychiatry 67: 148-159.
25. Binks CA, Fenton M, McCarthy L, Lee T, Adams CE, Duggan C, (2006). Pharmacological interventions for people with borderline personality disorder. Cochrane Database Syst Rev (1): CD005653.
26. Blondeau C, Dellu-Hagedorn F, (2007). Dimensional analysis of ADHD subtypes in rats. Biol Psychiatry 61: 1340-1350. (Pubitemid 46855765)
27. Bockaert J, Claeysen S, Becamel C, Dumuis A, Marin P, (2006). Neuronal 5-HT metabotropic receptors: fine-tuning of their structure, signaling, and roles in synaptic modulation. Cell Tissue Res 326: 553-572. (Pubitemid 44435826)
28. Boellner SW, Earl CQ, Arora S, (2006). Modafinil in children and adolescents with attention-deficit/hyperactivity disorder: a preliminary 8-week, open-label study. Curr Med Res Opin 22: 2457-2465. (Pubitemid 46048361)
29. Bonvento G, Scatton B, Claustre Y, Rouquier L, (1992). Effect of local injection of 8-OH-DPAT into the dorsal or median raphe nuclei on extracellular levels of serotonin in serotonergic projection areas in the rat brain. Neurosci Lett 137: 101-104.
30. Bornovalova MA, Daughters SB, Hernandez GD, Richards JB, Lejuez CW, (2005). Differences in impulsivity and risk-taking propensity between primary users of crack cocaine and primary users of heroin in a residential substance-use program. Exp Clin Psychopharmacol 13: 311-318. (Pubitemid 43011156)
31. van den Bos R, Lasthuis W, den Heijer E, van der Harst J, Spruijt B, (2006). Toward a rodent model of the Iowa gambling task. Behav Res Methods 38: 470-478.
32. Bowers MS, Chen BT, Bonci A, (2010). AMPA receptor synaptic plasticity induced by psychostimulants: the past, present, and therapeutic future. Neuron 67: 11-24.
33. Brown RT, Borden KA, Wynne ME, Schleser R, Clingerman SR, (1986). Methylphenidate and cognitive therapy with ADD children: a methodological reconsideration. J Abnorm Child Psychol 14: 481-497. (Pubitemid 17200806)
34. Brunner D, Hen R, (1997). Insights into the neurobiology of impulsive behavior from serotonin receptor knockout mice. Ann N Y Acad Sci 836: 81-105. (Pubitemid 28044021)
35. Burbassi S, Cervo L, (2008). Stimulation of serotonin2C receptors influences cocaine-seeking behavior in response to drug-associated stimuli in rats. Psychopharmacology (Berl) 196: 15-27.
36. Cardinal RN, Robbins TW, Everitt BJ, (2000). The effects of d-amphetamine, chlordiazepoxide, alpha- flupenthixol and behavioural manipulations on choice of signalled and unsignalled delayed reinforcement in rats. Psychopharmacology 152: 362-375.
37. Carli M, Samanin R, (2000). The 5-HT1A receptor agonist 8-OH-DPAT reduces rats' accuracy of attentional performance and enhances impulsive responding in a five-choice serial reaction time task: role of presynaptic 5- HT1A receptors. Psychopharmacology 149: 259-268. (Pubitemid 30262340)
38. Carli M, Robbins TW, Evenden JL, Everitt BJ, (1983). Effects of lesions to ascending noradrenergic neurons on performance of a 5-choice serial reaction time task in rats-implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav Brain Res 9: 361-380. (Pubitemid 13002330)
39. Chamberlain SR, Muller U, Blackwell AD, Clark L, Robbins TW, Sahakian BJ, (2006). Neurochemical modulation of response inhibition and probabilistic learning in humans. Science 311: 861-863. (Pubitemid 43228852)
40. Chamberlain SR, Muller U, Deakin JB, Corlett PR, Dowson J, Cardinal RN, et al,. (2007). Lack of deleterious effects of buspirone on cognition in healthy male volunteers. J Psychopharmacol 21: 210-215. (Pubitemid 46280474)
41. Chappell PB, Riddle MA, Scahill L, Lynch KA, Schultz R, Arnsten A, et al,. (1995). Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience. J Am Acad Child Adolesc Psychiatry 34: 1140-1146.
42. Chiamulera C, Epping-Jordan MP, Zocchi A, Marcon C, Cottiny C, Tacconi S, et al,. (2001). Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat Neurosci 4: 873-874. (Pubitemid 32801588)
43. Chu Z, Hablitz JJ, (1998). Activation of group I mGluRs increases spontaneous IPSC frequency in rat frontal cortex. J Neurophysiol 80: 621-627. (Pubitemid 28387646)
44. Clark L, Roiser JP, Cools R, Rubinsztein DC, Sahakian BJ, Robbins TW, (2005). Stop signal response inhibition is not modulated by tryptophan depletion or the serotonin transporter polymorphism in healthy volunteers: implications for the 5-HT theory of impulsivity. Psychopharmacology (Berl) 182: 570-578. (Pubitemid 41464639)
45. Cole BJ, Robbins TW, (1987). Amphetamine impairs the discriminative performance of rats with dorsal noradrenergic bundle lesions on a 5-choice serial reaction time task: new evidence for central dopaminergic-noradrenergic interactions. Psychopharmacology 91: 458-466. (Pubitemid 17038209)
46. Cole BJ, Robbins TW, (1989). Effects of 6-Hydroxydopamine lesions of the nucleus accumbens septi on performance of a 5-choice serial reaction time task in rats-implications for theories of selective attention and arousal. Behav Brain Res 33: 165-179. (Pubitemid 19141065)
47. Conners CK, Casat CD, Gualtieri CT, Weller E, Reader M, Reiss A, et al,. (1996). Bupropion hydrochloride in attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry 35: 1314-1321. (Pubitemid 26327705)
48. Connor DF, Rubin J, (2010). Guanfacine extended release in the treatment of attention deficit hyperactivity disorder in children and adolescents. Drugs Today (Barc) 46: 299-314.
49. Cox JM, Pappagallo M, (2001). Modafinil: a gift to portmanteau. Am J Hosp Palliat Care 18: 408-410.
50. Crean J, Richards JB, de Wit H, (2002). Effect of tryptophan depletion on impulsive behavior in men with or without a family history of alcoholism. Behav Brain Res 136: 349-357. (Pubitemid 35333250)
51. Dackis C, O'Brien C, (2003). Glutamatergic agents for cocaine dependence. Ann N Y Acad Sci 1003: 328-345. (Pubitemid 38083066)
52. Dalley JW, Cardinal RN, Robbins TW, (2004). Prefrontal executive and cognitive function in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev 28: 771-784. (Pubitemid 39535871)
53. Dalley JW, Fryer TD, Brichard L, Robinson ES, Theobald DE, Laane K, et al,. (2007). Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 315: 1267-1270. (Pubitemid 46364262)
54. Daviss WB, Patel NC, Robb AS, McDermott MP, Bukstein OG, Pelham WE, et al,. (2008). Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis. J Am Acad Child Adolesc Psychiatry 47: 189-198. (Pubitemid 351158787)
55. Del-Ben CM, Deakin JF, McKie S, Delvai NA, Williams SR, Elliott R, et al,. (2005). The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an FMRI study. Neuropsychopharmacology 30: 1724-1734. (Pubitemid 43090698)
56. Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ, (1999). Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet 354: 2132-2133. (Pubitemid 30008900)
57. Drueke B, Boecker M, Schlaegel S, Moeller O, Hiemke C, Grunder G, et al,. (2010). Serotonergic modulation of response inhibition and re-engagement? Results of a study in healthy human volunteers. Hum Psychopharmacol 25: 472-480.
58. D'Sa C, Eisch AJ, Bolger GB, Duman RS, (2005). Differential expression and regulation of the cAMP-selective phosphodiesterase type 4A splice variants in rat brain by chronic antidepressant administration. Eur J Neurosci 22: 1463-1475. (Pubitemid 41442418)
59. Eagle DM, Baunez C, (2010). Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition. Neurosci Biobehav Rev 34: 50-72.
60. Eagle DM, Robbins TW, (2003). Inhibitory control in rats performing a stop-signal reaction-time task: effects of lesions of the medial striatum and d-amphetamine. Behav Neurosci 117: 1302-1317. (Pubitemid 37549431)
61. Eagle DM, Tufft MR, Goodchild HL, Robbins TW, (2007). Differential effects of modafinil and methylphenidate on stop-signal reaction time task performance in the rat, and interactions with the dopamine receptor antagonist cis-flupenthixol. Psychopharmacology (Berl) 192: 193-206. (Pubitemid 46669203)
62. Eagle DM, Bari A, Robbins TW, (2008). The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/no-go tasks. Psychopharmacology (Berl) 199: 439-456.
63. Eagle DM, Lehmann O, Theobald DE, Pena Y, Zakaria R, Ghosh R, et al,. (2009). Serotonin depletion impairs waiting but not stop-signal reaction time in rats: implications for theories of the role of 5-HT in behavioral inhibition. Neuropsychopharmacology 34: 1311-1321.
64. Economidou D, Pelloux Y, Robbins TW, Dalley JW, Everitt BJ, (2009). High impulsivity predicts relapse to cocaine-seeking after punishment-induced abstinence. Biol Psychiatry 65: 851-856.
65. Ernst M, Zametkin AJ, Matochik JA, Jons PH, Cohen RM, (1998). DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [flourine-18]flourodopa positron emission tomographic study. J Neurosci 18: 5901-5907. (Pubitemid 28341366)
66. Evenden JL, (1999). Varieties of impulsivity. Psychopharmacology 146: 348-361. (Pubitemid 29513276)
67. Evenden JL, Ryan CN, (1996). The pharmacology of impulsive behaviour in rats: the effects of drugs on response choice with varying delays of reinforcement. Psychopharmacology 128: 161-170. (Pubitemid 26383303)
68. Faraone SV, Biederman J, (1998). Neurobiology of attention-deficit hyperactivity disorder. Biol Psychiatry 44: 951-958. (Pubitemid 28545223)
69. Feola TW, de Wit H, Richards JB, (2000). Effects of d-amphetamine and alcohol on a measure of behavioral inhibition in rats. Behav Neurosci 114: 838-848. (Pubitemid 30646573)
70. Fernie G, Cole JC, Goudie AJ, Field M, (2010). Risk-taking but not response inhibition or delay discounting predict alcohol consumption in social drinkers. Drug Alcohol Depend 112: 54-61.
71. Fillmore MT, Rush CR, (2002). Impaired inhibitory control of behavior in chronic cocaine users. Drug Alcohol Depend 66: 265-273. (Pubitemid 34327862)
72. Fillmore MT, Rush CR, Marczinski CA, (2003). Effects of d-amphetamine on behavioral control in stimulant abusers: the role of prepotent response tendencies. Drug Alcohol Depend 71: 143-152. (Pubitemid 37289024)
73. Fillmore MT, Rush CR, Hays L, (2005). Cocaine improves inhibitory control in a human model of response conflict. Exp Clin Psychopharmacol 13: 327-335. (Pubitemid 43011158)
74. Fillmore MT, Rush CR, Hays L, (2006). Acute effects of cocaine in two models of inhibitory control: implications of non-linear dose effects. Addiction 101: 1323-1332. (Pubitemid 44199524)
75. Fletcher PJ, Grottick AJ, Higgins GA, (2002). Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding. Neuropsychopharmacology 27: 576-586.
76. Fletcher PJ, Tampakeras M, Sinyard J, Higgins GA, (2007). Opposing effects of 5-HT(2A) and 5-HT (2C) receptor antagonists in the rat and mouse on premature responding in the five-choice serial reaction time test. Psychopharmacology (Berl) 195: 223-234. (Pubitemid 350045843)
77. Fletcher PJ, Le AD, Higgins GA, (2008a). Serotonin receptors as potential targets for modulation of nicotine use and dependence. Prog Brain Res 172: 361-383.
78. Fletcher PJ, Rizos Z, Sinyard J, Tampakeras M, Higgins GA, (2008b). The 5-HT2C receptor agonist Ro60-0175 reduces cocaine self-administration and reinstatement induced by the stressor yohimbine, and contextual cues. Neuropsychopharmacology 33: 1402-1412. (Pubitemid 351521717)
79. Frost DO, Tamminga CA, Medoff DR, Caviness V, Innocenti G, Carpenter WT, (2004). Neuroplasticity and schizophrenia. Biol Psychiatry 56: 540-543. (Pubitemid 39336400)
80. van Gaalen MM, Brueggeman RJ, Bronius PF, Schoffelmeer AN, Vanderschuren LJ, (2006a). Behavioral disinhibition requires dopamine receptor activation. Psychopharmacology (Berl) 187: 73-85. (Pubitemid 43876919)
81. van Gaalen MM, van Koten R, Schoffelmeer AN, Vanderschuren LJ, (2006b). Critical involvement of dopaminergic neurotransmission in impulsive decision making. Biol Psychiatry 60: 66-73.
82. van Gaalen MM, Unger L, Jongen-Relo AL, Schoemaker H, Gross G, (2009). Amphetamine decreases behavioral inhibition by stimulation of dopamine D2, but not D3, receptors. Behav Pharmacol 20: 484-491.
83. Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG, (1999). Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283: 397-401.
84. Gainetdinov RR, Mohn AR, Bohn LM, Caron MG, (2001). Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter. Proc Natl Acad Sci U S A 98: 11047-11054. (Pubitemid 32928681)
85. Gao XM, Hashimoto T, Cooper TB, Tamminga CA, (1997). The dose-response characteristics of rat oral dyskinesias with chronic haloperidol or clozapine administration. J Neural Transm 104: 97-104. (Pubitemid 27073233)
86. Gao XM, Sakai K, Tamminga CA, (1998). Chronic olanzapine or sertindole treatment results in reduced oral chewing movements in rats compared to haloperidol. Neuropsychopharmacology 19: 428-433. (Pubitemid 28451598)
87. Goddard AW, Shekhar A, Whiteman AF, McDougle CJ, (2008). Serotoninergic mechanisms in the treatment of obsessive-compulsive disorder. Drug Discov Today 13: 325-332.
88. Goudriaan AE, Oosterlaan J, de Beurs E, Van den Brink W, (2004). Pathological gambling: a comprehensive review of biobehavioral findings. Neurosci Biobehav Rev 28: 123-141. (Pubitemid 38692361)
89. Goudriaan AE, Oosterlaan J, de Beurs E, van den Brink W, (2005). Decision making in pathological gambling: a comparison between pathological gamblers, alcohol dependents, persons with Tourette syndrome, and normal controls. Brain Res Cogn Brain Res 23: 137-151. (Pubitemid 40417513)
90. Haaland VO, Landro NI, (2007). Decision making as measured with the Iowa Gambling Task in patients with borderline personality disorder. J Int Neuropsychol Soc 13: 699-703. (Pubitemid 350017944)
91. Hamidovic A, Kang UJ, de Wit H, (2008). Effects of low to moderate acute doses of pramipexole on impulsivity and cognition in healthy volunteers. J Clin Psychopharmacol 28: 45-51.
92. Harrison AA, Everitt BJ, Robbins TW, (1997). Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms. Psychopharmacology 133: 329-342. (Pubitemid 27462805)
93. Hart RP, Colenda CC, Hamer RM, (1991). Effects of buspirone and alprazolam on the cognitive performance of normal elderly subjects. Am J Psychiatry 148: 73-77.
94. Herning RI, Hooker WD, Jones RT, (1987). Cocaine effects on electroencephalographic cognitive event-related potentials and performance. Electroencephalogr Clin Neurophysiol 66: 34-42. (Pubitemid 17198989)
95. Herpertz SC, Zanarini M, Schulz CS, Siever L, Lieb K, Moller HJ, (2007). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of personality disorders. World J Biol Psychiatry 8: 212-244. (Pubitemid 350018476)
96. Hershey T, Black KJ, Hartlein J, Braver TS, Barch DM, Carl JL, et al,. (2004). Dopaminergic modulation of response inhibition: an fMRI study. Brain Res Cogn Brain Res 20: 438-448. (Pubitemid 38960676)
97. Higgins GA, Ouagazzal AM, Grottick AJ, (2001). Influence of the 5-HT(2C) receptor antagonist SB242,084 on behaviour produced by the 5-HT(2) agonist Ro60-0175 and the indirect 5-HT agonist dexfenfluramine. Br J Pharmacol 133: 459-466. (Pubitemid 32591911)
98. 2A receptor antagonist M100,907 attenuates motor and 'impulsive-like' behaviours produced by NMDA receptor antagonism. Psychopharmacology 170: 309-319. (Pubitemid 37491611)
99. Hogg J, Evans PL, (1975). Stimulus generalization following extra-dimensional training in educationally subnormal (severely) children. Br J Psychol 66: 211-224.
100. Holt DD, Green L, Myerson J, (2003). Is discounting impulsive? Evidence from temporal and probability discounting in gambling and non-gambling college students. Behav Processes 64: 355-367. (Pubitemid 37324379)
101. Hunt MK, Hopko DR, Bare R, Lejuez CW, Robinson EV, (2005). Construct validity of the Balloon Analog Risk Task (BART): associations with psychopathy and impulsivity. Assessment 12: 416-428. (Pubitemid 41703611)
102. Iversen SD, Mishkin M, (1970). Perseverative interference in monkeys following selective lesions of the inferior prefrontal convexity. Exp Brain Res 11: 376-386.
103. Iwamoto K, Takahashi M, Nakamura Y, Kawamura Y, Ishihara R, Uchiyama Y, et al,. (2008). The effects of acute treatment with paroxetine, amitriptyline, and placebo on driving performance and cognitive function in healthy Japanese subjects: a double-blind crossover trial. Hum Psychopharmacol 23: 399-407.
104. Jentsch JD, Taylor JR, (1999). Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology 146: 373-390. (Pubitemid 29513278)
105. Jentsch JD, Woods JA, Groman SM, Seu E, (2010). Behavioral characteristics and neural mechanisms mediating performance in a rodent version of the Balloon Analog Risk Task. Neuropsychopharmacology 35: 1797-1806.
106. Katzman MA, (2009). Current considerations in the treatment of generalized anxiety disorder. CNS Drugs 23: 103-120.
107. Kirby KN, Petry NM, Bickel WK, (1999). Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. J Exp Psychol Gen 128: 78-87.
108. Kjome KL, Lane SD, Schmitz JM, Green C, Ma L, Prasla I, et al,. (2010). Relationship between impulsivity and decision making in cocaine dependence. Psychiatry Res 178: 299-304.
109. Klorman R, Salzman LF, Bauer LO, Coons HW, Borgstedt AD, Halpern WI, (1983). Effects of two doses of methylphenidate on cross-situational and borderline hyperactive children's evoked potentials. Electroencephalogr Clin Neurophysiol 56: 169-185. (Pubitemid 13076354)
110. Klorman R, Brumaghim JT, Fitzpatrick PA, Borgstedt AD, (1991). Methylphenidate speeds evaluation processes of attention deficit disorder adolescents during a continuous performance test. J Abnorm Child Psychol 19: 263-283.
111. Koskinen T, Sirvio J, (2001). Studies on the involvement of the dopaminergic system in the 5- HT2 agonist (DOI)-induced premature responding in a five-choice serial reaction time task. Brain Res Bull 54: 65-75. (Pubitemid 32156917)
112. Koskinen T, Ruotsalainen S, Puumala T, Lappalainen R, Koivisto E, Mannisto PT, et al,. (2000). Activation of 5-HT2A receptors impairs response control of rats in a five-choice serial reaction time task. Neuropharmacology 39: 471-481. (Pubitemid 30052936)
113. Koskinen T, Haapalinna A, Sirvio J, (2003). Alpha-adrenoceptor-mediated modulation of 5-HT2 receptor agonist induced impulsive responding in a 5-choice serial reaction time task. Pharmacol Toxicol 92: 214-225. (Pubitemid 36513217)
114. Krause K-H, Dresel SH, Krause J, Kung HF, Tatsch K, (2000). Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography. Neurosci Lett 285: 107-110. (Pubitemid 30227631)
115. Lamm C, Zelazo PD, Lewis MD, (2006). Neural correlates of cognitive control in childhood and adolescence: disentangling the contributions of age and executive function. Neuropsychologia 44: 2139-2148. (Pubitemid 43993989)
116. Lane SD, Moeller FG, Steinberg JL, Buzby M, Kosten TR, (2007). Performance of cocaine dependent individuals and controls on a response inhibition task with varying levels of difficulty. Am J Drug Alcohol Abuse 33: 717-726. (Pubitemid 47463785)
117. Lee B, London ED, Poldrack RA, Farahi J, Nacca A, Monterosso JR, et al,. (2009). Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity. J Neurosci 29: 14734-14740.
118. Lejuez CW, Aklin WM, Jones HA, Richards JB, Strong DR, Kahler CW, et al,. (2003). The Balloon Analogue Risk Task (BART) differentiates smokers and nonsmokers. Exp Clin Psychopharmacol 11: 26-33. (Pubitemid 36237340)
119. LeMarquand DG, Benkelfat C, Pihl RO, Palmour RM, Young SN, (1999). Behavioral disinhibition induced by tryptophan depletion in nonalcoholic young men with multigenerational family histories of paternal alcoholism. Am J Psychiatry 156: 1771-1779. (Pubitemid 29517571)
120. Levin FR, Evans SM, McDowell DM, Brooks DJ, Nunes E, (2002). Bupropion treatment for cocaine abuse and adult attention-deficit/hyperactivity disorder. J Addict Dis 21: 1-16. (Pubitemid 35205006)
121. Li CS, Milivojevic V, Kemp K, Hong K, Sinha R, (2006). Performance monitoring and stop signal inhibition in abstinent patients with cocaine dependence. Drug Alcohol Depend 85: 205-212. (Pubitemid 44666277)
122. Li CS, Huang C, Yan P, Bhagwagar Z, Milivojevic V, Sinha R, (2008). Neural correlates of impulse control during stop signal inhibition in cocaine-dependent men. Neuropsychopharmacology 33: 1798-1806. (Pubitemid 351832590)
123. Li CS, Morgan PT, Matuskey D, Abdelghany O, Luo X, Chang JL, et al,. (2010). Biological markers of the effects of intravenous methylphenidate on improving inhibitory control in cocaine-dependent patients. Proc Natl Acad Sci U S A 107: 14455-14459.
124. Linnoila M, Virkkunen M, Scheinin M, Nuutila A, Rimon R, Goodwin FK, (1983). Low cerebrospinal-fluid 5-Hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci 33: 2609-2614. (Pubitemid 14203851)
125. Liu F, Grauer S, Kelley C, Navarra R, Graf R, Zhang G, et al,. (2008). ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]- piper idin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activities. J Pharmacol Exp Ther 327: 827-839.
126. Liu S, Heitz RP, Bradberry CW, (2009). A touch screen based Stop Signal Response Task in rhesus monkeys for studying impulsivity associated with chronic cocaine self-administration. J Neurosci Methods 177: 67-72.
127. Logan GD, (1994). On the ability to inhibit thought and action. A users' guide to the stop signal paradigm. In:, Dagenbach D, Carr TH, (eds). Inhibitory Processes in Attention, Memory and Language. Academic Press: San Diego, CA, pp. 189-236.
128. Loos M, Staal J, Schoffelmeer AN, Smit AB, Spijker S, Pattij T, (2010). Inhibitory control and response latency differences between C57BL/6J and DBA/2J mice in a Go/No-Go and 5-choice serial reaction time task and strain-specific responsivity to amphetamine. Behav Brain Res 214: 216-224.
129. Losier BJ, McGrath PJ, Klein RM, (1996). Error patterns on the continuous performance test in non-medicated and medicated samples of children with and without ADHD: a meta-analytic review. J Child Psychol Psychiatry 37: 971-987. (Pubitemid 26397633)
130. Lynch G, (2006). Glutamate-based therapeutic approaches: ampakines. Curr Opin Pharmacol 6: 82-88. (Pubitemid 43103823)
131. Lynch G, Gall CM, (2006). Ampakines and the threefold path to cognitive enhancement. Trends Neurosci 29: 554-562. (Pubitemid 44416457)
132. Madden GJ, Johnson PS, (2008). A delay-discounting primer. In:, Madden GJ, Bickel WK, (eds). Impulsivity the Behavioral and Neurological Science of Discounting. American Psychological Association: Washington, DC, pp. 11-38.
133. Malberg JE, Eisch AJ, Nestler EJ, Duman RS, (2000). Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20: 9104-9110. (Pubitemid 32042912)
134. Martinez-Raga J, Knecht C, Cepeda S, (2008). Modafinil: a useful medication for cocaine addiction? Review of the evidence from neuropharmacological, experimental and clinical studies. Curr Drug Abuse Rev 1: 213-221.
135. McGeehan AJ, Janak PH, Olive MF, (2004). Effect of the mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine (MPEP) on the acute locomotor stimulant properties of cocaine, d-amphetamine, and the dopamine reuptake inhibitor GBR12909 in mice. Psychopharmacology (Berl) 174: 266-273. (Pubitemid 38916301)
136. van der Meere J, Gunning B, Stemerdink N, (1999). The effect of methylphenidate and clonidine on response inhibition and state regulation in children with ADHD. J Child Psychol Psychiatry 40: 291-298. (Pubitemid 29078374)
137. Mendez IA, Simon NW, Hart N, Mitchell MR, Nation JR, Wellman PJ, et al,. (2010). Self-administered cocaine causes long-lasting increases in impulsive choice in a delay discounting task. Behav Neurosci 124: 470-477.
138. Milstein JA, Lehmann O, Theobald DE, Dalley JW, Robbins TW, (2007). Selective depletion of cortical noradrenaline by anti-dopamine beta-hydroxylase-saporin impairs attentional function and enhances the effects of guanfacine in the rat. Psychopharmacology (Berl) 190: 51-63. (Pubitemid 44885343)
139. Milstein J, Dalley J, Robbins T, (2010). Methylphenidate-induced impulsivity: pharmacological antagonism by {beta}-adrenoreceptor blockade. J Psychopharmacol 24: 309-321.
140. Mobini S, Chiang TJ, Ho MY, Bradshaw CM, Szabadi E, (2000). Effects of central 5-hydroxytryptamine depletion on sensitivity to delayed and probabilistic reinforcement. Psychopharmacology 152: 390-397.
141. Moeller FG, Barratt ES, Dougherty DM, Schmitz JM, Swann AC, (2001a). Psychiatric aspects of impulsivity. Am J Psychiatry 158: 1783-1793. (Pubitemid 33054770)
142. Moeller FG, Dougherty DM, Barratt ES, Schmitz JM, Swann AC, Grabowski J, (2001b). The impact of impulsivity on cocaine use and retention in treatment. J Subst Abuse Treat 21: 193-198. (Pubitemid 34037109)
143. Monterosso J, Ehrman R, Napier KL, O'Brien CP, Childress AR, (2001). Three decision-making tasks in cocaine-dependent patients: do they measure the same construct? Addiction 96: 1825-1837. (Pubitemid 34014260)
144. Morgan RE, Crowley JM, Smith RH, LaRoche RB, Dopheide MM, (2007). Modafinil improves attention, inhibitory control, and reaction time in healthy, middle-aged rats. Pharmacol Biochem Behav 86: 531-541. (Pubitemid 46466886)
145. Muir VJ, Perry CM, (2010). Guanfacine extended-release: in attention deficit hyperactivity disorder. Drugs 70: 1693-1702.
146. Muller U, Clark L, Lam ML, Moore RM, Murphy CL, Richmond NK, et al,. (2005). Lack of effects of guanfacine on executive and memory functions in healthy male volunteers. Psychopharmacology (Berl) 182: 205-213. (Pubitemid 41464613)
147. Napolitano F, Bonito-Oliva A, Federici M, Carta M, Errico F, Magara S, et al,. (2010). Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine. J Neurosci 30: 11043-11056.
148. Navarra R, Comery TA, Graf R, Rosenzweig-Lipson S, Day M, (2008a). The 5-HT(2C) receptor agonist WAY-163909 decreases impulsivity in the 5-choice serial reaction time test. Behav Brain Res 188: 412-415.
149. Navarra R, Graf R, Huang Y, Logue S, Comery T, Hughes Z, et al,. (2008b). Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test. Prog Neuropsychopharmacol Biol Psychiatry 32: 34-41.
150. Nic Dhonnchadha BA, Fox RG, Stutz SJ, Rice KC, Cunningham KA, (2009). Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaine-seeking behavior in a rat self-administration model. Behav Neurosci 123: 382-396.
151. Nose M, Cipriani A, Biancosino B, Grassi L, Barbui C, (2006). Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trials. Int Clin Psychopharmacol 21: 345-353. (Pubitemid 44498276)
152. Oquendo MA, Mann JJ, (2000). The biology of impulsivity and suicidality. Psychiatr Clin North Am 23: 11-25. (Pubitemid 30140469)
153. Overtoom CCE, Verbaten MN, Kemner C, Kenemans JL, van Engeland H, Buitelaar JK, et al,. (2003). Effects of methylphenidate, desipramine, and L-dopa on attention and inhibition in children with Attention Deficit Hyperactivity Disorder. Behav Brain Res 145: 7-15. (Pubitemid 37188627)
154. Overtoom CC, Bekker EM, van der Molen MW, Verbaten MN, Kooij JJ, Buitelaar JK, et al,. (2009). Methylphenidate restores link between stop-signal sensory impact and successful stopping in adults with attention-deficit/ hyperactivity disorder. Biol Psychiatry 65: 614-619.
155. Paine T, Olmstead MC, (2004). Cocaine discrupts both behavioural inhibition and conditional discrimination in rats. Psychopharmacology 175: 443-450. (Pubitemid 39362042)
156. Palumbo DR, Sallee FR, Pelham WE Jr, Bukstein OG, Daviss WB, McDermott MP, (2008). Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes. J Am Acad Child Adolesc Psychiatry 47: 180-188. (Pubitemid 351158786)
157. Passetti F, Dalley JW, Robbins TW, (2003). Double dissociation of serotonergic and dopaminergic mechanisms on attentional performance using a rodent five-choice reaction time task. Psychopharmacology 165: 136-145. (Pubitemid 36056990)
158. Pattij T, Vanderschuren LJ, (2008). The neuropharmacology of impulsive behaviour. Trends Pharmacol Sci 29: 192-199.
159. Pattij T, Janssen MC, Vanderschuren LJ, Schoffelmeer AN, van Gaalen MM, (2007). Involvement of dopamine D1 and D2 receptors in the nucleus accumbens core and shell in inhibitory response control. Psychopharmacology (Berl) 191: 587-598. (Pubitemid 46355887)
160. Patton JH, Stanford MS, Barratt ES, (1995). Factor structure of the Barratt impulsiveness scale. J Clin Psychol 51: 768-774. (Pubitemid 26021724)
161. Pentkowski NS, Duke FD, Weber SM, Pockros LA, Teer AP, Hamilton EC, et al,. (2010). Stimulation of medial prefrontal cortex serotonin 2C (5-HT(2C)) receptors attenuates cocaine-seeking behavior. Neuropsychopharmacology 35: 2037-2048.
162. Perry JL, Stairs DJ, Bardo MT, (2008). Impulsive choice and environmental enrichment: effects of d-amphetamine and methylphenidate. Behav Brain Res 193: 48-54.
163. Petry NM, (2001). Substance abuse, pathological gambling, and impulsiveness. Drug Alcohol Depend 63: 29-38. (Pubitemid 32288732)
164. Pine A, Shiner T, Seymour B, Dolan RJ, (2010). Dopamine, time, and impulsivity in humans. J Neurosci 30: 8888-8896.
165. Poulos CX, Le AD, Parker JL, (1995). Impulsivity predicts individual susceptibility to high levels of alcohol self-administration. Behav Pharmacol 6: 810-814.
166. Rachlin H, Raineri A, Cross D, (1991). Subjective probability and delay. J Exp Anal Behav 55: 233-244.
167. Rapoport JL, Buchsbaum MS, Zahn TP, Weingartner H, Ludlow C, Mikkelsen EJ, (1978). Dextroamphetamine: cognitive and behavioral effects in normal prepubertal boys. Science 199: 560-563. (Pubitemid 8298043)
168. Reynolds B, Schiffbauer R, (2004). Measuring state changes in human delay discounting: an experiential discounting task. Behav Processes 67: 343-356. (Pubitemid 39420142)
169. Reynolds B, Richards JB, de Wit H, (2006). Acute-alcohol effects on the Experiential Discounting Task (EDT) and a question-based measure of delay discounting. Pharmacol Biochem Behav 83: 194-202.
170. Riccio CA, Waldrop JJ, Reynolds CR, Lowe P, (2001). Effects of stimulants on the continuous performance test (CPT): implications for CPT use and interpretation. J Neuropsychiatry Clin Neurosci 13: 326-335. (Pubitemid 32743710)
171. Riddle MA, Nelson JC, Kleinman CS, Rasmusson A, Leckman JF, King RA, et al,. (1991). Sudden death in children receiving Norpramin: a review of three reported cases and commentary. J Am Acad Child Adolesc Psychiatry 30: 104-108.
172. Riddle MA, Geller B, Ryan N, (1993). Another sudden death in a child treated with desipramine. J Am Acad Child Adolesc Psychiatry 32: 792-797. (Pubitemid 23187778)
173. Riggs PD, Leon SL, Mikulich SK, Pottle LC, (1998). An open trial of bupropion for ADHD in adolescents with substance use disorders and conduct disorder. J Am Acad Child Adolesc Psychiatry 37: 1271-1278. (Pubitemid 28550719)
174. Rivalan M, Ahmed SH, Dellu-Hagedorn F, (2009). Risk-prone individuals prefer the wrong options on a rat version of the Iowa Gambling Task. Biol Psychiatry 66: 743-749.
175. Robbins TW, (2002). The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology 163: 362-380.
176. Robinson ES, Eagle DM, Mar AC, Bari A, Banerjee G, Jiang X, et al,. (2008). Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropsychopharmacology 33: 1028-1037. (Pubitemid 351367544)
177. Rosvold HE, Mirsky AF, Sarason I, Bransome ED, Beck LH, (1956). A continuous performance test of brain damage. J Consult Psychol 20: 343-350.
178. Rubia K, Russell T, Overmeyer S, Brammer MJ, Bullmore ET, Sharma T, et al,. (2001). Mapping motor inhibition: conjunctive brain activations across different versions of go/no-go and stop tasks. Neuroimage 13: 250-261. (Pubitemid 34185014)
179. Ruotsalainen S, Sirvio J, Jakala P, Puumala T, MacDonald E, Riekkinen P, (1997). Differential effects of three 5-HT receptor antagonists on the performance of rats in attentional and working memory tasks. Eur Neuropsychopharmacol 7: 99-108. (Pubitemid 27240343)
180. Saunders EF, Silk KR, (2009). Personality trait dimensions and the pharmacological treatment of borderline personality disorder. J Clin Psychopharmacol 29: 461-467.
181. Scahill L, Chappell PB, Kim YS, Schultz RT, Katsovich L, Shepherd E, et al,. (2001). A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry 158: 1067-1074. (Pubitemid 32623110)
182. Schweighofer N, Bertin M, Shishida K, Okamoto Y, Tanaka SC, Yamawaki S, et al,. (2008). Low-serotonin levels increase delayed reward discounting in humans. J Neurosci 28: 4528-4532.
183. Sharp T, Umbers V, Hjorth S, (1996). The role of 5-HT1A autoreceptors and alpha(1)-adrenoceptors in the inhibition of 5-HT release.2. NAN-190 and SDZ 216-525. Neuropharmacology 35: 735-741. (Pubitemid 26308550)
184. Shiels K, Hawk LW Jr, Reynolds B, Mazzullo RJ, Rhodes JD, Pelham WE, et al,. (2009). Effects of methylphenidate on discounting of delayed rewards in attention deficit/hyperactivity disorder. Exp Clin Psychopharmacol 17: 291-301.
185. Shurman B, Horan WP, Nuechterlein KH, (2005). Schizophrenia patients demonstrate a distinctive pattern of decision-making impairment on the Iowa Gambling Task. Schizophr Res 72: 215-224. (Pubitemid 39550992)
186. Simpson D, Perry CM, (2003). Atomoxetine. Paediatr Drugs 5: 407-415. (Pubitemid 36745671)
187. Singer HS, Brown J, Quaskey S, Rosenberg LA, Mellits ED, Denckla MB, (1995). The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine. Pediatrics 95: 74-81.
188. Solanto MV, Abikoff H, Sonuga-Barke EJS, Schachar R, Logan GD, Wigal T, et al,. (2001). The ecological validity of delay aversion and response inhibition as measures of impulsivity in AD/HD: a supplement to the NIMH multi-modal treatment study of AD/HD. J Abnorm Child Psychol 29: 215-228. (Pubitemid 33745807)
189. Sonuga-Barke EJS, (2003). The dual pathway model of AD/HD: an elaboration of neuro-developmental characteristics. Neurosci Biobehav Rev 27: 593-604. (Pubitemid 37414908)
190. Sostek AJ, Buchsbaum MS, Rapoport JL, (1980). Effects of amphetamine on vigilance performance in normal and hyperactive children. J Abnorm Child Psychol 8: 491-500. (Pubitemid 11189829)
191. Soubrie P, (1986). Reconciling the role of central serotonin neurons in human and animal behavior. Behav Brain Sci 9: 319-364.
192. Spencer TJ, (2009). Toward a new understanding of attention-deficit hyperactivity disorder: advances in research and treatment. CNS Drugs 23 (Suppl. 1): 5-8.
193. Spencer T, Biederman J, Coffey B, Geller D, Crawford M, Bearman SK, et al,. (2002a). A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/ hyperactivity disorder. Arch Gen Psychiatry 59: 649-656. (Pubitemid 34747245)
194. Spencer TJ, Biederman J, Wilens TE, Faraone SV, (2002b). Novel treatments for attention-deficit/hyperactivity disorder in children. J Clin Psychiatry 63 (Suppl. 12): 16-22. (Pubitemid 36025583)
195. Stanis JJ, Burns RM, Sherrill LK, Gulley JM, (2008). Disparate cocaine-induced locomotion as a predictor of choice behavior in rats trained in a delay-discounting task. Drug Alcohol Depend 98: 54-62.
196. Sun H, Green TA, Theobald DE, Birnbaum SG, Graham DL, Zeeb FD, et al,. (2010). Yohimbine increases impulsivity through activation of cAMP response element binding in the orbitofrontal cortex. Biol Psychiatry 67: 649-656.
197. Swann AC, Birnbaum D, Jagar AA, Dougherty DD, Moeller FG, (2005). Acute yohimbine increases laboratory-measured impulsivity in normal subjects. Biol Psychiatry 57: 1209-1211. (Pubitemid 40615785)
198. Swanson JM, (2003). Role of executive function in ADHD. J Clin Psychiatry 64 (Suppl. 14): 35-39. (Pubitemid 37445018)
199. Talpos JC, Wilkinson LS, Robbins TW, (2006). A comparison of multiple 5-HT receptors in two tasks measuring impulsivity. J Psychopharmacol 20: 47-58.
200. Tannock R, Schachar R, Carr RP, Chajczyk D, Logan GD, (1989). Effects of methylphenidate on inhibitory control in hyperactive children. J Abnorm Child Psychol 17: 473-491. (Pubitemid 19261803)
201. Terman M, Terman JS, (1973). Latency differentiation of hits and false alarms in an operant-psychophysical test. J Exp Anal Behav 20: 439-445.
202. Tripp G, Wickens JR, (2009). Neurobiology of ADHD. Neuropharmacology 57: 579-589.
203. Tsutsui-Kimura I, Ohmura Y, Izumi T, Yamaguchi T, Yoshida T, Yoshioka M, (2009). The effects of serotonin and/or noradrenaline reuptake inhibitors on impulsive-like action assessed by the three-choice serial reaction time task: a simple and valid model of impulsive action using rats. Behav Pharmacol 20: 474-483.
204. Turner DC, Robbins TW, Clark L, Aron AR, Dowson J, Sahakian BJ, (2003). Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology (Berl) 165: 260-269. (Pubitemid 36197601)
205. Turner DC, Clark L, Dowson J, Robbins TW, Sahakian BJ, (2004). Modafinil improves cognition and response inhibition in adult attention-deficit/ hyperactivity disorder. Biol Psychiatry 55: 1031-1040. (Pubitemid 38581919)
206. Vaidya CJ, Austin G, Kirkorian G, Ridlehuber HW, Desmond JE, Glover GH, et al,. (1998). Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. Proc Natl Acad Sci U S A 95: 14494-14499. (Pubitemid 28549395)
207. Vansickel AR, Fillmorex MT, Hays LR, Rush CR, (2008). Effects of potential agonist-replacement therapies for stimulant dependence on inhibitory control in cocaine abusers. Am J Drug Alcohol Abuse 34: 293-305. (Pubitemid 351572454)
208. Verbruggen F, Logan GD, (2009). Models of response inhibition in the stop-signal and stop-change paradigms. Neurosci Biobehav Rev 33: 647-661.
209. Verdejo-Garcia A, Benbrook A, Funderburk F, David P, Cadet JL, Bolla KI, (2007a). The differential relationship between cocaine use and marijuana use on decision-making performance over repeat testing with the Iowa Gambling Task. Drug Alcohol Depend 90: 2-11. (Pubitemid 46935369)
210. Verdejo-Garcia AJ, Perales JC, Perez-Garcia M, (2007b). Cognitive impulsivity in cocaine and heroin polysubstance abusers. Addict Behav 32: 950-966. (Pubitemid 46282289)
211. Volkow ND, Fowler JS, (2000). Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex 10: 318-325. (Pubitemid 30159298)
212. Vollm B, Richardson P, McKie S, Reniers R, Elliott R, Anderson IM, et al,. (2010). Neuronal correlates and serotonergic modulation of behavioural inhibition and reward in healthy and antisocial individuals. J Psychiatr Res 44: 123-131.
213. Voon V, Fernagut PO, Wickens J, Baunez C, Rodriguez M, Pavon N, et al,. (2009). Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders. Lancet Neurol 8: 1140-1149.
214. Walderhaug E, Lunde H, Nordvik JE, Landro NI, Refsum H, Magnusson A, (2002). Lowering of serotonin by rapid tryptophan depletion increases impulsiveness in normal individuals. Psychopharmacology 164: 385-391. (Pubitemid 35435714)
215. Walderhaug E, Magnusson A, Neumeister A, Lappalainen J, Lunde H, Refsum H, et al,. (2007). Interactive effects of sex and 5-HTTLPR on mood and impulsivity during tryptophan depletion in healthy people. Biol Psychiatry 62: 593-599. (Pubitemid 47314384)
216. Walderhaug E, Landro NI, Magnusson A, (2008). A synergic effect between lowered serotonin and novel situations on impulsivity measured by CPT. J Clin Exp Neuropsychol 30: 204-211.
217. Walderhaug E, Herman AI, Magnusson A, Morgan MJ, Landro NI, (2010). The short (S) allele of the serotonin transporter polymorphism and acute tryptophan depletion both increase impulsivity in men. Neurosci Lett 473: 208-211.
218. Waters KA, Burnham KE, O'Connor D, Dawson GR, Dias R, (2005). Assessment of modafinil on attentional processes in a five-choice serial reaction time test in the rat. J Psychopharmacol 19: 149-158. (Pubitemid 40577219)
219. Weingartner H, Rapoport JL, Buchsbaum MS, Bunney WE Jr, Ebert MH, Mikkelsen EJ, et al,. (1980). Cognitive processes in normal and hyperactive children and their response to amphetamine treatment. J Abnorm Psychol 89: 25-37. (Pubitemid 10101177)
220. Wilens TE, Biederman J, Prince J, Spencer TJ, Faraone SV, Warburton R, et al,. (1996). Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry 153: 1147-1153. (Pubitemid 26299833)
221. Wilkinson RT, (1963). Interaction of noise with knowledge of results and sleep deprivation. J Exp Psychol 66: 332-337.
222. Williams WA, Grant JE, Winstanley CA, Potenza MN, (2008). Current concepts in the classification, treatment and modeling of pathological gambling and other impulse control disorders. In:, McArthur RA, Borsini F, (eds). Reward Deficit Disorders. Elsevier: Burlington, MA, pp. 317-357.
223. Wilson HK, Cox DJ, Merkel RL, Moore M, Coghill D, (2006). Effect of extended release stimulant-based medications on neuropsychological functioning among adolescents with Attention-Deficit/Hyperactivity Disorder. Arch Clin Neuropsychol 21: 797-807. (Pubitemid 44693173)
224. Wingen M, Kuypers KP, Ramaekers JG, (2007). The role of 5-HT1a and 5-HT2a receptors in attention and motor control: a mechanistic study in healthy volunteers. Psychopharmacology (Berl) 190: 391-400. (Pubitemid 46155648)
225. Winstanley CA, (2007). The orbitofrontal cortex, impulsivity and addiction: probing orbitofrontal dysfunction at the neural, neurochemical and molecular level. Ann N Y Acad Sci 1121: 639-655.
226. Winstanley CA, (2010). The neural and neurochemical basis of delay discounting. In:, Madden GJ, Bickel WK, (eds). Impulsivity the Behavioral and Neurological Science of Discounting. American Psychological Association: Washington, DC, pp. 95-122.
227. Winstanley CA, Chudasama Y, Dalley JW, Theobald DE, Glennon JC, Robbins TW, (2003a). Intra-prefrontal 8-OH-DPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats. Psychopharmacology 167: 304-314. (Pubitemid 36712978)
228. Winstanley CA, Theobald DE, Dalley JW, Robbins TW, (2003b). Global 5-HT depletion attenuates the ability of amphetamine to decrease impulsive choice in rats. Psychopharmacology 170: 320-331. (Pubitemid 37491612)
229. Winstanley CA, Theobald DE, Dalley JW, Glennon JC, Robbins TW, (2004). 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion. Psychopharmacology 176: 376-385. (Pubitemid 40012745)
230. Winstanley CA, Theobald DE, Dalley JW, Robbins TW, (2005). Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders. Neuropsychopharmacology 30: 669-682. (Pubitemid 40397073)
231. Winstanley CA, Eagle DM, Robbins TW, (2006). Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies. Clin Psychol Rev 26: 379-395.
232. Winstanley CA, LaPlant Q, Theobald DEH, Green TA, Bachtell RK, Perrotti LI, et al,. (2007). DeltaFosB induction in orbitofrontal cortex mediates tolerance to cocaine-induced cognitive dysfunction. J Neurosci 27: 10497-10507. (Pubitemid 47502009)
233. Winstanley CA, Bachtell RK, Theobald DE, Laali S, Green TA, Kumar A, et al,. (2009). Increased impulsivity during withdrawal from cocaine self-administration: role for DeltaFosB in the orbitofrontal cortex. Cereb Cortex 19: 435-444.
234. Winstanley CA, Olausson P, Taylor JR, Jentsch JD, (2010a). Insight into the relationship between impulsivity and substance abuse from studies using animal models. Alcohol Clin Exp Res 34: 1306-1318.
235. Winstanley CA, Zeeb FD, Bedard A, Fu K, Lai B, Steele C, et al,. (2010b). Dopaminergic modulation of the orbitofrontal cortex affects attention, motivation and impulsive responding in rats performing the five-choice serial reaction time task. Behav Brain Res 210: 263-272.
236. de Wit H, Crean J, Richards JB, (2000). Effects of d-amphetamine and ethanol on a measure of behavioral inhibition in humans. Behav Neurosci 114: 830-837. (Pubitemid 30646572)
237. de Wit H, Enggasser JL, Richards JB, (2002). Acute administration of d-amphetamine decreases impulsivity in healthy volunteers. Neuropsychopharmacology 27: 813-825. (Pubitemid 35335897)
238. Wogar MA, Bradshaw CM, Szabadi E, (1993). Effects of lesions of the ascending 5-hydroxytryptaminergic pathways on choice between delayed reinforcers. Psychopharmacology 111: 239-243. (Pubitemid 23135086)
239. Yip SW, Sacco KA, George TP, Potenza MN, (2009). Risk/reward decision-making in schizophrenia: a preliminary examination of the influence of tobacco smoking and relationship to Wisconsin Card Sorting Task performance. Schizophr Res 110: 156-164.
240. Zack M, Poulos CX, (2008). Effects of the atypical stimulant modafinil on a brief gambling episode in pathological gamblers with high vs. low impulsivity. J Psychopharmacol 23: 660-671.
241. Zeeb FD, Robbins TW, Winstanley CA, (2009). Serotonergic and dopaminergic modulation of gambling behavior as assessed using a novel rat gambling task. Neuropsychopharmacology 34: 2329-2343.
242. Zeeb FD, Floresco SB, Winstanley CA, (2010). Contributions of the orbitofrontal cortex to impulsive choice: interactions with basal levels of impulsivity, dopamine signalling, and reward-related cues. Psychopharmacology (Berl) 211: 87-98.